Can ¹⁸F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors

References

• LiuRSYehSHHuangMHUse of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary reportEur J Nucl Med19952212142147
   Google Scholar
• SasakiMKuwabaraYIchiyaYDifferential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PETJ Nucl Med199940101595160110520697
   PubMed Web of Science ®Google Scholar
• SungYMLeeKSKimBTChoiJYShimYMYiCA18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroupsJ Nucl Med200647101628163417015898
   PubMed Web of Science ®Google Scholar
• EndoMNakagawaKOhdeYUtility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumorsLung Cancer200861335035518304691
   PubMed Web of Science ®Google Scholar
• LuzziLCampioneAGorlaARole of fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal massesEur J Cardiothorac Surg200936347547919501523
   PubMed Web of Science ®Google Scholar
• ShibataHNomoriHUnoK18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymomaCancer2009115112531253819326456
   PubMed Web of Science ®Google Scholar
• InoueATomiyamaNTatsumiM18F-FDG PET for the evaluation of thymic epithelial tumors: correlation with the World Health Organization classification in addition to dual-time-point imagingEur J Nucl Med Mol Imaging20093681219122519219429
   PubMed Web of Science ®Google Scholar
• KumarARegmiSKDuttaRCharacterization of thymic masses using 18F-FDG PET-CTAnn Nucl Med200923656957719585212
   PubMed Web of Science ®Google Scholar
• TerziABertolacciniLRizzardiGUsefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasmsLung Cancer201174223924321439670
   PubMed Web of Science ®Google Scholar
• FukumotoKTaniguchiTIshikawaYThe utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumoursEur J Cardiothorac Surg2012426e15215623024234
   PubMed Web of Science ®Google Scholar
• EguchiTYoshidaKHamanakaKUtility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumoursEur J Cardiothorac Surg20124151059106222219437
   PubMed Web of Science ®Google Scholar
• LococoFCesarioAOkamiJRole of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysisLung Cancer201382224525123992878
   PubMed Web of Science ®Google Scholar
• BenvenisteMFMoranCAMawlawiOFDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignanciesJ Thorac Oncol20138450251023446204
   PubMed Web of Science ®Google Scholar
• MatsumotoIOdaMTakizawaMUsefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumorsAnn Thorac Surg201395130531023200236
   PubMed Web of Science ®Google Scholar
• TobaHKondoKSadoharaY18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumoursEur J Cardiothorac Surg2013442e10511223674658
   PubMed Web of Science ®Google Scholar
• ParkSYChoABaeMKLeeCYKimDJChungKYValue of 18F-FDG PET/CT for predicting the World Health Organization malignant grade of thymic epithelial tumors: focused in volume-dependent parametersClin Nucl Med2016411152026545017
   PubMed Web of Science ®Google Scholar
• NCCN Clinical Practice Guidelines in OncologyThymomas and Thymic Carcinomas Available from: http://www.nccn.org/professionals/physician_gls/PDF/thymic.pdfAccessed September 1, 2017
   Google Scholar
• TravisWDBrambillaEBurkeAPMarxANicholsonAGWHO Classification of Tumours of the Lung, Pleura, Thymus and Heart4th editionLyonIARC2015
   Google Scholar
• MarchevskyAMGuptaRMcKennaRJEvidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinomaCancer200815112122780278818442102
   PubMed Web of Science ®Google Scholar
• WeisCAYaoXDengYContributors to the ITMIG Retrospective DatabaseThe impact of thymoma histotype on prognosis in a worldwide databaseJ Thorac Oncol201510236737225616178
   PubMed Web of Science ®Google Scholar
• BrierleyJDGospodarowiczMKWittekindCTNM Classification of Malignant Tumours8th edNew YorkWiley-Blackwell2017
   Google Scholar
• den BakkerMARodenACMarxAMarinoMHistologic classification of thymoma: a practical guide for routine casesJ Thorac Oncol201499 Suppl 2S125S13025396309
   PubMed Web of Science ®Google Scholar
• TomiyamaNMüllerNLEllisSJInvasive and noninvasive thymoma: distinctive CT featuresJ Comput Assist Tomogr20012538839311351188
   PubMed Web of Science ®Google Scholar
• TokerASonettJZielinskiMReaFTomulescuVDetterbeckFCStandard terms, definitions, and policies for minimally invasive resection of thymomaJ Thorac Oncol201167 Suppl 3S1739174221847056
   PubMed Web of Science ®Google Scholar
• AhmadUYaoXDetterbeckFThymic carcinoma outcomes and prognosis: results of an international analysisJ Thorac Cardiovasc Surg201514919510025524678
   PubMed Web of Science ®Google Scholar
• YanoMSasakiHMoriyamaSClinicopathological analysis of small-sized anterior mediastinal tumorsSurg Today201444101817182224065193
   PubMed Web of Science ®Google Scholar
• RodenACYiESJenkinsSMModified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classificationsJ Thorac Oncol201510469170025629638
   PubMed Web of Science ®Google Scholar
• FukuiTFukumotoKOkasakaTClinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest GroupEur J Cardiothorac Surg201649257457926547095
   PubMed Web of Science ®Google Scholar
• ShankarLKHoffmanJMBacharachSConsensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute TrialsJ Nucl Med20064761059106616741317
   PubMed Web of Science ®Google Scholar
• ThomasAMenaEKurdzielK18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumorsClin Cancer Res20131961487149323382114
   PubMed Web of Science ®Google Scholar